Company / PP&E per Share
Dyne Therapeutics, Inc. PP&E per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.05
FY2024
5-year range
$0.05 / $0.14
FY2020-FY2024
Trend
-32.2%
vs FY2023
Sector context
#115 of 193
Health Care
What the data says
At $0.05, Dyne Therapeutics, Inc.'s pp&e per share ranks #115 of 193 in the Health Care sector. Declined from $0.11 to $0.05 over the past 2 years.
Based on SEC 10-K filings.
0.05 in FY2024 with a 5-year CAGR of -38.7%.
Declined from $0.11 to $0.05 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -16.9%
- 5-Year CAGR
- -38.7%
- 10-Year CAGR
- -
Sector benchmark
#115 of 193 in Health CareTop 60% of 193This company $0.05 Sector average $18.71
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2024, pp&e per share decreased 32.2% year-over-year.
- Ranks #115 out of 193 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.05 | -32.2% |
| FY2023 | $0.08 | -27.2% |
| FY2022 | $0.11 | +16.3% |
| FY2021 | $0.09 | -32.0% |
| FY2020 | $0.14 | -77.8% |
| FY2019 | $0.61 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026